This study evaluates whether an ultrasound procedure named “super-resolution ultrasound localization microscopy,” is able to detect any residual bladder cancer before bladder removal surgery.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT06986304.
Locations matching your search criteria
United States
North Carolina
Durham
Duke University Medical CenterStatus: Active
Contact: Michael Abern
Phone: 919-684-2443
PRIMARY OBJECTIVE:
I. To determine the safety and feasibility of SR-ULM in detecting residual BC in patients undergoing RC as measured by histopathologic analysis.
OUTLINE: This is an observational study.
Patients receive sulfur hexafluoride lipid microspheres (Lumason) intravenously (IV) and undergo ultrasound on study.
Trial PhaseNo phase specified
Trial Typedevice
Lead OrganizationDuke University Medical Center
Principal InvestigatorMichael Abern